Target intelligence / Profile preview

Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated transcription pathway (NF-κB pathway)

Target
NF-κB pathway
Molecular classification
Signaling pathway, Transcription factor pathway
01

Overview

The NFκB-mediated transcription pathway is a crucial cellular signaling cascade that regulates the activity of the NF-κB family of transcription factors. It controls gene expression in response to various stimuli, including inflammatory signals, stress, cytokines, free radicals, and pathogens. Activation leads to the translocation of NF-κB dimers into the nucleus, where they bind DNA and regulate the transcription of genes involved in inflammation, immunity, cell survival, and proliferation. Dysregulation of this pathway is implicated in cancer and chronic inflammatory diseases.

Other names
NFκB pathwayNF-kB signaling pathwayNF-kappaB pathwayNF-kappa B signaling pathwayNFkB mediated transcription
02

Mechanism of action

Varies depending on the specific drug; examples include inhibition of IKK, inhibition of proteasomal degradation of IκB, inhibition of NF-κB DNA binding, and reduction of upstream activating signals.

03

Biological functions

InflammationImmune responseCell proliferationCell differentiationCell survivalApoptosisLymphoid organogenesisBone metabolismGene transcription
04

Disease associations

CancerChronic inflammatory diseasesAutoimmune diseasesInfection
05

Safety considerations

ImmunosuppressionIncreased risk of infectionPotential for off-target effectsContext-dependent effects (activation vs. inhibition can have different consequences in different cell types)
06

Interacting drugs

IKK inhibitors

5 more in the full profile.

07

Biomarkers

NF-κB subunit expression levelsIκB phosphorylation levelsExpression of NF-κB target genes (e.g., cytokines, chemokines)

Beyond the preview

Go deeper on Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated transcription pathway (NF-κB pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated transcription pathway (NF-κB pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call